Further studies on the effects of intracrine and extracellular angiotensin II on the regulation of heart cell volume. On the influence of aldosterone and spironolactone

Regulatory Peptides

Volumn 165, Issue 2-3, 2010, Pages 200-205

  De Mello, W C ^a   Gerena, Y ^a  

^a UNIVERSITY OF PUERTO RICO   (Puerto Rico)

Author keywords

Aldosterone; Angiotensin II; AT1 receptor expression failing heart; Cell volume; Intracrine; Spironolactone

Indexed keywords

ALDOSTERONE; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; SPIRONOLACTONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAMERA; CARDIOMYOPATHY; CELL SIZE; CELL SWELLING; CELL VOLUME; CHLORIDE CURRENT; COMPUTER ANALYSIS; CONTROLLED STUDY; EXTRACELLULAR SPACE; HAMSTER; HEART FAILURE; HEART MUSCLE CELL; HEART VENTRICLE; HORMONAL REGULATION; HORMONE RESPONSE; INTRACELLULAR SPACE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ALDOSTERONE; ANGIOTENSIN II; ANIMALS; CELL SIZE; CELLS, CULTURED; CRICETINAE; FLOW CYTOMETRY; MEMBRANE TRANSPORT PROTEINS; MYOCYTES, CARDIAC; SPIRONOLACTONE;

CRICETINAE;

EID: 78049474036     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2010.07.165     Document Type: Article

References (29)

1. Lang F., Busch G.L., Ritter M., Volkl H., et al. Functional significance of cell volume regulatory mechanisms. Physiol Rev 1998, 78:247-3062.
2. Baumgarten C.M., Clemo H.F. Swelling-activated chloride channels in cardiac physiology and pathophysiology. Prog Biophys Mol Biol 2003, 122:689-702.
3. - cotransport by cGMP and atrial natriuretic factor. J Gen Physiol 1992, 100:89-114.
4. De Mello W.C. Cell swelling, impulse conduction and cardiac arrhythmias in the failing heart. Opposite effects of angiotensin II and angiotensin (1-7) on cell volume regulation. Mol Cell Biochem 2009, 330:211-217.
5. Wang G.L., Wang G.X., Yamamoto S., Ye L., et al. Molecular mechanisms of regulation of fast-inactivating voltage-dependent transient outward K+ current in mouse heart by cell volume changes. J Physiol 2005, 568:423-443.
6. Duan D.Y., Liu L.L., Bozeat N., Huang Z.M., et al. Functional role of anion channel in cardiac diseases. Acta Pharmacol Sin 2005, 26:265-278.
7. Sarota S. Swelling-induced chloride-sensitive current in canine atrial cells revealed by the whole cell patch clamp. Circ Res 1992, 70:679-687.
8. Sackin H. Stretch-activated ion channels. Kidney Int 1995, 48:1134-1147.
9. - current by angiotensin II signalling and NADPH oxidase in rabbit ventricle. Cardiovasc Res 2008, 77:73-80.
10. De Mello W.C., Gerena Y. Eplererenone inhibits the intracrine and extracellular actions of angiotensin II on the inward calcium current in the failing heart. On the presence of an intracrine renin angiotensin aldosterone system. Regul Pept 2008, 151:54-60.
11. De Mello W.C. Intracellular and extracellular renin have opposite effects on the regulation of heart cell volume. Implications to myocardial ischemia. J Renin Angiotensin Aldosterone Syst 2008, 9:112-118.
12. Powell T., Twist T. A rapid technique for isolation and purification of adult cardiac muscle cells having respiratory control and a tolerance to calcium. Biochem Biophys Res Commun 1976, 72:327-333.
13. Tanigushi Y., Kokubun S., Noma A., Irisawa H. Spontaneously active cells isolated from the sinoatrial and atrioventricular node of the rabbit heart. Jpn J Physiol 1981, 31:547-558.
14. Clemo H.F., Stambler B.S., Baumgarten C.M. Swelling-activated chloride current is persistently activated in ventricular myocytes from dogs with tachycardia-induced congestive heart failure. Circ Res 1999, 84:157-165.
15. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survive Study (CONSENSUS). N Engl J Med 1987, 316:1429-1435. The CONSENSUS Trial Study Group.
16. Cohn J.N., Johnson G., Zieshe S., et al. A comparison of enalapril with hydralazine isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 1991, 325:303-310.
17. Otani H., Matsuhisa S., Akita Y., Kyoi S., Enoki C., et al. Role of mechanical stress in the form of cardiomyocyte death during the early phase of reperfusion. Circ J 2006, 70:1344-1355.
18. Pitt B., Zannad F., Remme W.J., et al. The effect of spironolactone on morbility and mortality in patients with severe heart failure. N Engl J Med 1999, 341:709-717. for the Ramdomized Aldactone Evaluation Study Investigators.
19. Pitt B. Effect of aldosterone blockade in patients with systolic left ventricular dysfunction: implications of the RALES and EPHESUS studies. Mol Cell Endocrinol 2004, 217:53-58.
20. De Mello W.C. Beneficial effect of eplerenone on cardiac remodeling and electrical properties of the failing heart. J Renin Angiotensin Aldosterone Syst 2006, 7:40-46.
21. Miyajima K., Minatogushi S., Ito Y., Hukunishi M., et al. Reduction of QTc dispersion by the angiotensin II receptor blocker valsartan may be related to its anti-oxidative stress effect in patients with essential hypertension. Hypertens Res 2007, 30:307-313.
22. Matsui S., Satoh H., Kawashima H., Nagasaka S., et al. Non-genomic effects of aldosterone on intracellular ion regulation and cell volume in rat ventricular myocytes. Can J Physiol Pharmacol 2007, 85:264-273.
23. Ekhterae D., Platoshyn O., Zhang S., Remillard C.V., Yuan J.X. Apoptosis repressor with caspase domain inhibits cardiomyocyte apoptosis by reducing K+ currents. Am J Physiol Cell Physiol 2003, 284:C1405-C1410.
24. - current densities in hypertrophied ventricular myocytes of rabbits with heart failure. Cardiovasc Res 2002, 53:869-878.
25. Boyett M.R., Frampton J.E., Kirby M.S. The length, width and volume of isolated rat and ferret ventricular myocytes during twitch contractions and changes in osmotic strength. Exp Physiol 1991, 76:259-270.
26. Sorenson A.L., Tepper D., Sonneblick E.H., Robinson T.F., Capasso J.M. Size and shape of enzymatically isolated ventricular myocytes from rats and cardiomyopathic hamsters. Cardiovasc Res 1985, 19:793-799.
27. Mizuno Y., Yoshimura M., Yasue H., et al. Aldosterone production is activated in failing ventricles of humans. Circulation 2001, 103:72-77.
28. Gomez-Sanchez E., Ahmad N., Romero D.G., Gomez-Sanchez C.E. Origin of aldosterone in the rat heart. Endocrinology 2004, 145:4796-4802.
29. Fiebeler A., Nussberger J., Schgdarsuren E., Rong S., Hilfenhaus G., Al-Saadi N., et al. Aldosterone synthase inhibitor ameliorates angiotensin II-induced organ damage. Circulation 2005, 111:3087-3094.